Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typic...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6093645?pdf=render |
id |
doaj-f5b186e643ef4ec7a8e8c5001ba1a445 |
---|---|
record_format |
Article |
spelling |
doaj-f5b186e643ef4ec7a8e8c5001ba1a4452020-11-25T01:46:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020128210.1371/journal.pone.0201282Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.Eli B NixJoshua ChoiChristina AnthesGabrielle N GaultierJoelle ThorgrimsonAndrew D CoxRaymond S W TsangWilliam G McCreadyDouglas BorehamMarina UlanovaDuring the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typically develop invasive Hia disease. To clarify factors responsible for an increased burden of invasive Hia disease in certain population groups we studied serum bactericidal activity (SBA) against Hia and quantified IgG and IgM specific to Hia capsular polysaccharide in healthy adult members of two First Nations communities: 1) with reported cases of invasive Hia disease (Northern Ontario, NO), and 2) without reported cases (Southern Ontario, SO), in comparison to non-First Nations living in proximity to the NO First Nations community, and non-First Nations elderly non-frail Canadians from across the country (total of 110 First Nations and 76 non-First Nations). To elucidate the specificity of bactericidal antibodies, sera were absorbed with various Hia antigens. Naturally acquired SBA against Hia was detected at higher rates in First Nations (NO, 80%; SO, 96%) than non-First Nations elderly Canadians (64%); the SBA titres in First Nations were higher than in non-First Nations elderly Canadians (P<0.001) and NO non-First Nations adults (P>0.05). Among First Nations, SBA was mediated predominantly by IgM, and by both antibodies specific to Hia capsular polysaccharide and lipooligosaccharide. CONCLUSIONS:The SBA against Hia is frequently present in sera of First Nations adults regardless of the burden of Hia disease observed in their community; it may represent part of the natural antibody repertoire, which is potentially formed in this population under the influence of certain epigenetic factors. Although the nature of these antibodies deserves further studies to understand their origin, the data suggest that they may represent important protective mechanism against invasive Hia disease.http://europepmc.org/articles/PMC6093645?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eli B Nix Joshua Choi Christina Anthes Gabrielle N Gaultier Joelle Thorgrimson Andrew D Cox Raymond S W Tsang William G McCready Douglas Boreham Marina Ulanova |
spellingShingle |
Eli B Nix Joshua Choi Christina Anthes Gabrielle N Gaultier Joelle Thorgrimson Andrew D Cox Raymond S W Tsang William G McCready Douglas Boreham Marina Ulanova Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study. PLoS ONE |
author_facet |
Eli B Nix Joshua Choi Christina Anthes Gabrielle N Gaultier Joelle Thorgrimson Andrew D Cox Raymond S W Tsang William G McCready Douglas Boreham Marina Ulanova |
author_sort |
Eli B Nix |
title |
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study. |
title_short |
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study. |
title_full |
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study. |
title_fullStr |
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study. |
title_full_unstemmed |
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study. |
title_sort |
characterization of natural bactericidal antibody against haemophilus influenzae type a in canadian first nations: a canadian immunization research network (cirn) clinical trials network (ctn) study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typically develop invasive Hia disease. To clarify factors responsible for an increased burden of invasive Hia disease in certain population groups we studied serum bactericidal activity (SBA) against Hia and quantified IgG and IgM specific to Hia capsular polysaccharide in healthy adult members of two First Nations communities: 1) with reported cases of invasive Hia disease (Northern Ontario, NO), and 2) without reported cases (Southern Ontario, SO), in comparison to non-First Nations living in proximity to the NO First Nations community, and non-First Nations elderly non-frail Canadians from across the country (total of 110 First Nations and 76 non-First Nations). To elucidate the specificity of bactericidal antibodies, sera were absorbed with various Hia antigens. Naturally acquired SBA against Hia was detected at higher rates in First Nations (NO, 80%; SO, 96%) than non-First Nations elderly Canadians (64%); the SBA titres in First Nations were higher than in non-First Nations elderly Canadians (P<0.001) and NO non-First Nations adults (P>0.05). Among First Nations, SBA was mediated predominantly by IgM, and by both antibodies specific to Hia capsular polysaccharide and lipooligosaccharide. CONCLUSIONS:The SBA against Hia is frequently present in sera of First Nations adults regardless of the burden of Hia disease observed in their community; it may represent part of the natural antibody repertoire, which is potentially formed in this population under the influence of certain epigenetic factors. Although the nature of these antibodies deserves further studies to understand their origin, the data suggest that they may represent important protective mechanism against invasive Hia disease. |
url |
http://europepmc.org/articles/PMC6093645?pdf=render |
work_keys_str_mv |
AT elibnix characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT joshuachoi characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT christinaanthes characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT gabriellengaultier characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT joellethorgrimson characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT andrewdcox characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT raymondswtsang characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT williamgmccready characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT douglasboreham characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT marinaulanova characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy |
_version_ |
1725018917277007872 |